Published on 18 Jun 2024 on Simply Wall St. · via Yahoo Finance
With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a...
Key Insights
Significantly high institutional ownership implies Allogene Therapeutics' stock price is sensitive to their trading actionsThe top 8 shareholders own 51% of the company Recent sales by insiders
A look at the shareholders of Allogene Therapeutics, Inc. (NASDAQ:ALLO) can tell us which group is most powerful. With 56% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).